Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy

Details for Australian Patent Application No. 2003298873 (hide)

Owner Millennium Pharmaceuticals, Inc.

Inventors Morrissey, Michael P.; Mulligan, George; Bolt, Andrew; Damokosh, Andrew I.; Bryant, Barbara M.

Agent Davies Collison Cave

Pub. Number AU-B-2003298873

PCT Number PCT/US2003/0385

PCT Pub. Number WO2004/053066

Priority 60/431,514 06.12.02 US

Filing date 4 December 2003

Wipo publication date 30 June 2004

Acceptance publication date 1 September 2011

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

Event Publications

6 May 2004 Complete Application Filed

  Priority application(s): 60/431,514 06.12.02 US

5 August 2004 Application Open to Public Inspection

  Published as AU-B-2003298873

1 September 2011 Application Accepted

  Published as AU-B-2003298873

12 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003298874-A tool and a method for creating a tool

2003298872-SYSTEM AND A NON-PLANAR PRISM THAT ARE USED TO OBTAIN PRINT AND OTHER HAND CHARACTERISTIC INFORMATION